Login
$ARXS
$52.64 -$0.09 (0.17%) Close

$ARXS SEC Filings

Filed On Filing
22 Oct 2026 EFFECT
22 Oct 2026 424B3
13 Oct 2026 S-1
21 Sep 2026 SCHEDULE 13G
21 Aug 2026 Form 4: Roth Jason Aaron, See Remarks

Received 34,098 shares as a grant or award

18 Aug 2026 8-K: Completion of Acquisition or Disposition of Assets; Unregistered Sales of Equity Securities
14 Aug 2026 SCHEDULE 13G
12 Aug 2026 SCHEDULE 13G
12 Aug 2026 SCHEDULE 13G
30 Jul 2026 10-Q
29 Jul 2026 8-K: Results of Operations and Financial Condition
01 Jul 2026 Form 4: Jankowski Ryan Anthony, Chief Accounting Officer

Received 8,517 shares as a grant or award

02 Jun 2026 8-K: Entry into a Material Definitive Agreement; Other Events
28 May 2026 8-K: Results of Operations and Financial Condition
28 May 2026 10-Q
20 Apr 2026 Form 4: Jankowski Ryan Anthony, Chief Accounting Officer

Received 46,867 shares as a grant or award · Bought 4,464 shares ($125K)

20 Apr 2026 Form 4: Allen Jennifer H., See Remarks

Received 53,695 shares as a grant or award

20 Apr 2026 Form 4: Badakhsh Azad Sid, See Remarks

Received 367,864 shares as a grant or award · Bought 36,000 shares ($1.01M)

20 Apr 2026 Form 4: Sealfon Ross Bradley, See Remarks

Received 1,090,307 shares as a grant or award · Bought 12,500 shares ($350K)

20 Apr 2026 Form 4: Oetgen Stephen Duane, Director

Received 5,357 shares as a grant or award · Bought 25,000 shares ($700K)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support